IUPAC/Chemical Name
Benzamide, 4-amino-N-(1-(5-((4,6-dideoxy-4-(dimethylamino)-alpha-D-glucopyranosyl)oxy)tetrahydro-6-methyl-2H-pyran-2-yl)-1,2-dihydro-2-oxo-4-pyrimidinyl)-, (2R-(2-alpha,5-beta,6-alpha))-
InChi Key
NFOMJDXALJABQF-SIPWQYCSSA-N
InChi Code
InChI=1S/C25H35N5O7/c1-13-17(37-24-22(32)21(31)20(29(3)4)14(2)36-24)9-10-19(35-13)30-12-11-18(28-25(30)34)27-23(33)15-5-7-16(26)8-6-15/h5-8,11-14,17,19-22,24,31-32H,9-10,26H2,1-4H3,(H,27,28,33,34)/t13-,14+,17+,19-,20+,21-,22+,24+/m0/s1
SMILES Code
O=C(NC(C=CN1[C@@H]2CC[C@@H](O[C@@H]3[C@@H]([C@H]([C@H](N(C)C)[C@@H](C)O3)O)O)[C@H](C)O2)=NC1=O)C4=CC=C(N)C=C4
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
517.58
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Bu YY, Yamazaki H, Ukai K, Namikoshi M. Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A. Mar Drugs. 2014 Dec 17;12(12):6102-12. doi: 10.3390/md12126102. PubMed PMID: 25522318; PubMed Central PMCID: PMC4278220.
2: SENSI P, GRECO AM, GALLO GG, ROLLAND G. Isolation and structure determination of a new amicetin-like antibiotic: amicetin B. Antibiot Chemother (Northfield). 1957 Dec;7(12):645-52. PubMed PMID: 24544597.
3: Konstantinova NV, Fedorova GB, Borisova VN, Shapovalova SP, Malkova IV. [Isolation and identification of the antibiotics amicetin and nebramycin formed by a Streptomyces coeruleoaurantiacus 4009 culture]. Antibiotiki. 1982 Jun;27(6):403-9. Russian. PubMed PMID: 7114825.
4: Duvall EJ, Mongkolsuk S, Kim UJ, Lovett PS, Henkin TM, Chambliss GH. Induction of the chloramphenicol acetyltransferase gene cat-86 through the action of the ribosomal antibiotic amicetin: involvement of a Bacillus subtilis ribosomal component in cat induction. J Bacteriol. 1985 Feb;161(2):665-72. PubMed PMID: 3918021; PubMed Central PMCID: PMC214934.
5: Weisblum B, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol. 1969 May;98(2):447-52. PubMed PMID: 5784204; PubMed Central PMCID: PMC284837.
6: Swaminathan V, Smith JL, Sundaralingam M, Coutsogeorgopoulos C, Kartha G. Crystal and molecular structure of the antibiotic blasticidin S hydrochloride pentahydrate. Biochim Biophys Acta. 1981 Oct 27;655(3):335-41. PubMed PMID: 7284390.
7: Rogers EJ, Ambulos NP Jr, Gu Z, Lovett PS. Parallel induction strategies for cat-86: separating chloramphenicol induction from protein synthesis inhibition. Mol Microbiol. 1993 Jun;8(6):1063-9. PubMed PMID: 7689687.